Clinical Trial Update: A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy

View source ↗

Summary

This clinical trial update describes a qualitative study assessing the severity and impact of rheumatic immune-related adverse events, such as arthritis and pol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Polymyalgia Rheumatica

Drugs mentioned

• Immune checkpoint inhibitors (various)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Arthritis, Polymyalgia Rheumatica | Status: RECRUITING